Uncategorized

FDA and NIH Announce Innovative Joint Nutrition Regulatory Science Program Source: FDA Press Releases

The U.S. Food and Drug Administration today announced it granted three new color additive petitions that will expand the palette of available colors from natural sources for manufacturers to safely use in food. Source: FDA Press Releases

FDA announced an aggressive timeline to scale AI across all centers by June 30. Source: FDA Press Releases

The U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients. Source: FDA Press Releases

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make America Healthy Again. Source: FDA Press Releases

FDA Commissioner Martin A. Makary, M.D., M.P.H. announces a policy directive that limits individuals employed at companies regulated by the FDA from serving as official members on FDA advisory committees, where statutorily allowed Source: FDA Press Releases

The U.S. Food and Drug Administration today welcomed HHS Secretary Robert F. Kennedy, Jr. to its headquarters in Silver Spring, Maryland, a visit that included remarks to FDA employees, meetings with agency leadership, and a tour of several medical device innovation laboratories on the Campus Source: FDA Press Releases

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs Source: FDA Press Releases

Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P.H., took the oath of office to become the 27th Commissioner of Food and Drugs. Source: FDA Press Releases

Today, the U.S. Food and Drug Administration approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies). Source: FDA Press Releases